Reitz Capital Advisors’s Medtronic MDT Stock Holding History

Reitz Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-150	Closed	-$14K	–	85
2020 Q2	$14K	Buy	+150	New	+$14.4K	0.02%	99

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Reitz Capital Advisors's MDT Position: Q3 2020 in Review

Reitz Capital Advisors sold out of Medtronic (MDT) in Q3 2020, closing a stake of 150 shares — an estimated $14K sold.

Reitz Capital Advisors first reported a position in MDT in Q2 2020 and held it in 1 quarter. The position peaked at $14K in Q2 2020. 1,810 funds tracked by Wall St. Rank hold MDT as of Q3 2020.

Reitz Capital Advisors reported no remaining Medtronic position as of Q3 2020 after selling out during the quarter.
Reitz Capital Advisors sold 150 Medtronic shares in Q3 2020, an estimated $14K.
Reitz Capital Advisors first reported a position in Medtronic in Q2 2020 and held it in 1 quarter.
Reitz Capital Advisors's Medtronic position peaked at $14K in Q2 2020.
1,810 funds tracked by Wall St. Rank held Medtronic as of Q3 2020.

Based on Reitz Capital Advisors's 13F filing for Q3 2020, filed 19 Oct 2020.